New NIH COVID-19 research includes insights on coronavirus’ effect on patients’ brains; blood thinner trial enrollment paused

Jan 04, 2021 - 02:32 PM
NIH research

New research conducted by the National Institutes of Health is shedding light on how COVID-19 affects patients’ brains.

Researchers reported evidence of damage caused by thinning and leaky brain blood vessels in tissue samples from patients who died shortly after contracting COVID-19. However, there were no signs of SARS-CoV-2 in tissue samples, suggesting the damage was not caused by a direct viral attack on the brain.

NIH Dec. 22 also announced it paused enrollment for one group of patients participating in three clinical trial platforms working in conjunction with one another to test the effects of full doses of anticoagulants in COVID-19 patients.

Researchers determined that among critically ill COVID-19 patients requiring intensive care unit support, therapeutic anticoagulation drugs did not reduce the need for organ support. The trials will continue enrollment of moderately ill hospitalized COVID-19 patients.

Several other NIH-led studies are also providing new insights in the following areas:

  • the likelihood of SARS-CoV-2 infection transmission between third-trimester pregnant women and newborns;
  • a series of investigations into risk factors for COVID-19-related inflammatory syndrome in children; and
  • support for new, non-traditional approaches and reimagined uses of existing tools to address gaps in COVID-19 testing and surveillance.

Related News Articles

Headline
CDC adopts ACIP recommendations for COVID-19, chickenpox vaccines
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
FDA seeks feedback on measuring AI-enabled medical device performance
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
Olympus recalls endoscope needles
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
ACIP recommends patients consult their provider for COVID-19 vaccine
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
HHS announces efforts to improve long COVID care 
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
FDA issues serious recall for electric wheelchair joysticks
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…